Hair Follicle Drug Testing Center

Prelude Therapeutics is a Wilmington, DE-based precision oncology company dedicated to developing innovative medicines for cancer patients facing high unmet needs. With a focus on precise targeting of cancer cell growth drivers and resistance mechanisms, the company is advancing a pipeline of first-in-class drug candidates, including selective SMARCA2 and KAT6A degraders, as well as next-generation antibody drug conjugates (ADCs). Committed to a bold scientific approach, Prelude Therapeutics emphasizes the importance of leveraging insights from both biology and chemistry to tackle challenging cancer treatments. The company's mission is to extend the promise of precision medicine to every cancer patient, providing hope through the development of safe, effective, and durable therapies. Generated from the website